Seer, Inc. (SEER)Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
1.98 USD
-0.03
(-1.493%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.97 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:41 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:51 a.m. EDT
The investment case here is defined by a stark disconnect between the company's deteriorating fundamentals and the aggressive optimism of retail traders. Fundamentally, the business is in freefall: revenue has contracted by nearly 24% year-over-year, operating margins are deeply negative at -5.4%, and the stock has lost 94% of its value over the last four years. Despite a recent 30% price rally following an investor update, the underlying economics remain broken with negative free cash flow and a lack of sustainable profitability. However, the short-term outlook is driven entirely by a hostile proxy battle rather than operational recovery. Activist investors are pushing for board changes and a potential sale, creating a binary event-driven scenario that explains the recent price surge. The options market confirms this sentiment, with massive call positioning and zero put protection, indicating a speculative bet on a takeover or activist victory rather than a belief in the company's standalone future. For a traditional investor, the multi-year decline and eroding value make this a dangerous hold, but for a trader betting on the resolution of the activist standoff, the asymmetric upside remains the only compelling thesis. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.162656 |
| MSTL | 0.162706 |
| AutoETS | 0.162766 |
| AutoTheta | 0.165186 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 11.25 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.040 |
| Excess Kurtosis | -1.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.921 |
| Revenue per Share | 0.254 |
| Market Cap | 109,636,592 |
| Forward P/E | -1.94 |
| Beta | 1.52 |
| Website | https://seer.bio |
As of Aug. 22, 2026, 3:51 a.m. EDT: Speculators are overwhelmingly bullish on upside potential, evidenced by significant open interest in out-of-the-money calls (strikes $5.00) compared to virtually zero put activity. Implied volatility is heavily skewed toward calls, suggesting a bet on a rally rather than a hedge against downside.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.014705896 |
| Address1 | 3,800 Bridge Parkway |
| Address2 | Suite 102 |
| All Time High | 86.55 |
| All Time Low | 1.455 |
| Ask | 1.99 |
| Ask Size | 1 |
| Audit Risk | 3 |
| Average Daily Volume10 Day | 170,380 |
| Average Daily Volume3 Month | 1,057,341 |
| Average Volume | 1,057,341 |
| Average Volume10Days | 170,380 |
| Beta | 1.522 |
| Bid | 1.43 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 4.081 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.98 |
| Current Ratio | 14.742 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.0185 |
| Day Low | 1.98 |
| Debt To Equity | 9.921 |
| Display Name | Seer |
| Earnings Call Timestamp End | 1,786,480,200 |
| Earnings Call Timestamp Start | 1,786,480,200 |
| Earnings Timestamp | 1,786,478,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -64,850,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.321 |
| Enterprise To Revenue | -1.465 |
| Enterprise Value | -20,826,410 |
| Eps Current Year | -1.1 |
| Eps Forward | -1.02 |
| Eps Trailing Twelve Months | -1.21 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.0196 |
| Fifty Day Average Change | -0.039599895 |
| Fifty Day Average Change Percent | -0.019607792 |
| Fifty Two Week Change Percent | -1.4705896 |
| Fifty Two Week High | 2.41 |
| Fifty Two Week High Change | -0.43000007 |
| Fifty Two Week High Change Percent | -0.17842326 |
| Fifty Two Week Low | 1.55 |
| Fifty Two Week Low Change | 0.43000007 |
| Fifty Two Week Low Change Percent | 0.27741942 |
| Fifty Two Week Range | 1.55 - 2.41 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,607,092,200,000 |
| Float Shares | 40,528,993 |
| Forward Eps | -1.02 |
| Forward P E | -1.9411765 |
| Free Cashflow | -26,797,500 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 124 |
| Fullday Change | -0.03 |
| Fullday Change Percent | -1.49254 |
| Fullday Price | 1.97 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.47696 |
| Gross Profits | 6,781,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14512 |
| Held Percent Institutions | 0.50778 |
| Implied Shares Outstanding | 55,372,015 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-12-04 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. |
| Long Name | Seer, Inc. |
| Market | us_market |
| Market Cap | 109,636,592 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_548496461 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -67,964,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 111,574,610 |
| Number Of Analyst Opinions | 1 |
| Open | 2.01 |
| Operating Cashflow | -43,379,000 |
| Operating Margins | -5.42908 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 650 453 0000 |
| Post Market Change | -0.00999999 |
| Post Market Change Percent | -0.50505 |
| Post Market Price | 1.97 |
| Post Market Time | 1,787,960,462 |
| Previous Close | 2.01 |
| Price Eps Current Year | -1.8 |
| Price Hint | 4 |
| Price To Book | 0.48517522 |
| Price To Sales Trailing12 Months | 7.7116547 |
| Profit Margins | 0.0 |
| Quick Ratio | 13.871 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -1.49254 |
| Regular Market Day High | 2.0185 |
| Regular Market Day Low | 1.98 |
| Regular Market Day Range | 1.98 - 2.0185 |
| Regular Market Open | 2.01 |
| Regular Market Previous Close | 2.01 |
| Regular Market Price | 1.98 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 155,366 |
| Return On Assets | -0.15288 |
| Return On Equity | -0.26447 |
| Revenue Growth | -0.234 |
| Revenue Per Share | 0.254 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 55,372,015 |
| Shares Percent Shares Out | 0.0022 |
| Shares Short | 123,029 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 148,052 |
| Short Name | Seer, Inc. |
| Short Percent Of Float | 0.0025 |
| Short Ratio | 0.14 |
| Source Interval | 15 |
| State | CA |
| Symbol | SEER |
| Target High Price | 4.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 4.0 |
| Target Median Price | 4.0 |
| Total Cash | 152,852,992 |
| Total Cash Per Share | 2.76 |
| Total Debt | 22,390,000 |
| Total Revenue | 14,217,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.21 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.896775 |
| Two Hundred Day Average Change | 0.08322501 |
| Two Hundred Day Average Change Percent | 0.043877114 |
| Type Disp | Equity |
| Volume | 155,366 |
| Website | https://seer.bio |
| Zip | 94,065 |